Joint Accreditation Statement

In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation

Practicing Clinicians Exchange designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation

Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit

AAPA Credit Designation

Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credit. Approval is valid until November 29, 2021. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

This activity is supported by educational grants from AbbVie Inc., Celgene Corporation, Gilead Sciences, Inc., and Sanofi Genzyme.

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Tesser: advisory board/consultant: Arena Pharmaceuticals, Sanofi-Genzyme/Regeneron; advisory board/consultant/research support: Gilead, Novartis, Samumed; advisory board/consultant/research support/speakers bureau: AbbVie, Amgen, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals, Lilly, Pfizer, UCB; advisory board/consultant/speakers bureau: Crescendo Bioscience/Myriad, Medac; research support: Ablynx, AstraZeneca, Aurinia Pharmaceuticals, Biogen, Boehringer Ingelheim, Celgene, Eicos Sciences, GlaxoSmithKline, Horizon Therapeutics, Mallinckrodt, Merck KG, R-Pharma, Radius, Roche, Sandoz, Sanofi, Scipher Medicine, SetPoint Medical, Takeda, Sun Pharma; research support/speakers bureau: Regeneron; speakers bureau: Sanofi-Genzyme.

Dr Melton: consultant: Gilead, Janssen; speakers bureau: AbbVie, Amgen, Exagen, Myriad Autoimmune, Novartis, Pfizer, Sanofi Genzyme, UCB.

Dr Simpson: advisory board/consultant: Sanofi Genzyme; speakers bureau: AbbVie.

Ms Cole has no relevant financial relationships to disclose.

None of the members of the PCE staff have any relevant relationships to disclose.

Participants wishing to earn CE/CME credit must:

1. View the content in its entirety
2. Relate the content material to the learning objectives
3. Complete the post-test and evaluation form

Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.

The estimated time to complete this activity is 0.50 hours.

Release date: November 30, 2020

Expiration date: November 29, 2021

For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.